Policy briefing: Making 'good targets' for translational research
Morrison M.
This is the first of four policy briefings from the Biomodifying technologies project. In this briefing, the team set out our understanding of a 'good clinical target' in each of the areas studied: gene editing, induced pluripotent stem cells (iPSCs) and 3D bioprinting.